Electrocardiogram — Cost, Top Hospitals & Success Rates | MyMedicPlus

The electrocardiogram (ECG, also called EKG from the German Elektrokardiogramm) is a fundamental, non-invasive diagnostic tool that records the electrical activity of the heart over a period of time, typically 10 seconds. The heart's electrical conduction system — originating in the sinoatrial (SA) node and propagating through the atrioventricular (AV) node, Bundle of His, bundle branches, and Purkinje fibres — generates electrical impulses that spread across the cardiac muscle to coordinate each heartbeat. The ECG captures these signals through electrodes placed on the skin surface, translating them into characteristic waveforms: the P wave (atrial depolarisation), QRS complex (ventricular depolarisation), and T wave (ventricular repolarisation).

A standard 12-lead ECG records cardiac electrical activity from 12 different anatomical viewpoints (leads), providing a comprehensive spatial picture of electrical activity in the frontal and horizontal planes. This multi-lead representation allows clinicians to localise pathology to specific regions of the heart — for example, ST elevation in leads II, III, and aVF indicates inferior myocardial infarction (right coronary artery territory), while ST changes in V1–V4 suggest anterior infarction (left anterior descending artery territory). The ECG is one of the most widely used diagnostic tools in medicine, performed in emergency departments, cardiology outpatient clinics, preoperative assessment, intensive care units, and primary care settings worldwide.

The ECG requires no patient preparation, carries no radiation exposure, causes no discomfort beyond electrode placement, and delivers results within minutes. It can be performed at the bedside, in an ambulance, in a GP surgery, and increasingly via smartphone-attached single-lead devices used at home. Continuous ECG monitoring (telemetry) is available in hospital settings for high-risk cardiac patients, and ambulatory ECG monitoring (Holter monitor, implantable loop recorder) extends monitoring to days, weeks, or years.

The ECG is invaluable for diagnosing a wide spectrum of cardiac conditions. Myocardial infarction (heart attack) — the most time-critical cardiac emergency — is diagnosed on ECG by ST segment elevation in specific lead territories, indicating acute occlusion of a coronary artery requiring emergency reperfusion (primary PCI or thrombolysis). Non-ST-elevation MI (NSTEMI) is identified by ST depression and T-wave changes, while evolving MI may show Q waves as evidence of irreversible myocardial necrosis. The ECG is also the primary diagnostic tool for arrhythmias, including atrial fibrillation (irregular, absent P waves, irregular QRS), atrial flutter (characteristic sawtooth pattern), supraventricular tachycardias, ventricular tachycardia, ventricular fibrillation, and bradyarrhythmias.

Heart block — failure of conduction through the AV node or bundle branches — is diagnosed by specific ECG patterns: first-degree block (prolonged PR interval), second-degree block (Mobitz I Wenckebach or Mobitz II patterns), and third-degree (complete) heart block (P waves and QRS complexes completely dissociated). Preexcitation syndromes such as Wolff-Parkinson-White (WPW) are identified by a short PR interval and delta wave. QT prolongation — a marker of risk for potentially lethal torsades de pointes arrhythmia — is identified and monitored. Structural conditions including left and right ventricular hypertrophy, pericarditis (saddle-shaped ST elevation in multiple leads), and pulmonary embolism (S1Q3T3 pattern, right heart strain) are also characterised on ECG.

An ECG is indicated for virtually any patient with cardiac symptoms: chest pain or discomfort, palpitations, syncope or near-syncope, dyspnoea, and fatigue where a cardiac cause is suspected. It is a mandatory first-line investigation in any emergency presentation that could represent acute coronary syndrome (ACS), arrhythmia, or pulmonary embolism. Routine preoperative ECGs are performed for patients undergoing major surgery (particularly those over 40 or with cardiovascular risk factors) to establish a baseline and detect previously unrecognised cardiac disease.

There are no absolute contraindications to a standard ECG. It is safe for all patients including children, pregnant women, elderly patients, and those with implanted devices (pacemakers, ICDs — the ECG does not interfere with these devices). In patients with implanted pacemakers, the ECG shows pacing spikes and is used to assess pacemaker function and sensing. Patients with skin conditions, burns, or wounds at electrode sites may have suboptimal electrode contact but the procedure can still be attempted. Hairy skin surfaces may require electrode gel or shaving to improve contact quality.

Several types of ECG monitoring are available depending on the clinical question. The standard 12-lead ECG is the baseline investigation for most cardiac assessments, capturing 10 seconds of cardiac electrical activity in 12 leads. Exercise (stress) ECG — performed while the patient walks on a treadmill or cycles on an ergometer with progressive intensity — is used to detect exercise-induced myocardial ischaemia (ST changes on exertion), assess arrhythmias provoked by exercise, and evaluate chronotropic competence. It is performed in cardiac stress laboratories with emergency resuscitation equipment available.

Ambulatory ECG monitoring (Holter monitoring) records continuous ECG for 24–48 hours or up to 14 days using a small wearable device, enabling correlation of cardiac rhythm with patient symptoms such as palpitations, syncope, and dyspnoea. For infrequent symptoms (monthly syncope episodes), implantable loop recorders — small subcutaneous devices implanted under local anaesthesia — can continuously monitor cardiac rhythm for up to 3 years and transmit data remotely. Telemetry ECG monitoring is performed continuously in hospital settings for patients with acute cardiac events, post-cardiac surgery, or arrhythmia risk. Smartphone-attached single-lead ECG devices (such as the AliveCor KardiaMobile) allow patients to record a clinician-readable ECG at home, increasingly used for AF monitoring. Shared decision-making between the patient and specialist ensures the chosen modality aligns with individual anatomy, comorbidities, risk tolerance, and personal goals. A formal consultation with a board-certified specialist, review of pre-treatment imaging or investigation results, and multidisciplinary team input for complex cases are standard practice before finalising the treatment plan.

The ECG is unparalleled in providing rapid, non-invasive, cost-effective cardiac diagnostic information that directly guides life-saving treatment decisions. In acute STEMI, a diagnostic ECG obtained within 10 minutes of presentation is a key performance standard — the earlier the diagnosis, the earlier the reperfusion therapy, and clinical outcomes (survival, heart muscle salvage) are directly proportional to time-to-treatment. In the emergency setting, ECG diagnoses that prompt immediate intervention include VF (requiring immediate defibrillation), VT (antiarrhythmic therapy or defibrillation), complete heart block (temporary pacing), and hyperacute STEMI (emergency PCI activation).

For outpatient cardiology, the ECG provides a permanent, reproducible record of baseline cardiac electrical activity that can be compared on serial follow-up to detect interval changes. Long-term ambulatory monitoring identifies arrhythmia diagnoses in 25–30% of patients investigated for unexplained palpitations or syncope, guiding management decisions including ablation, antiarrhythmic therapy, or pacemaker implantation. Population screening programmes using ECG have been implemented in several countries for conditions such as hypertrophic cardiomyopathy (in competitive athletes) and Brugada syndrome (in high-risk families), preventing sudden cardiac death in identifiable at-risk individuals.

The resting 12-lead ECG is one of the safest medical investigations with essentially zero direct procedural risk. Electrode placement is non-invasive; no electrical current is passed through the patient (the ECG only records, it does not transmit electricity). Skin irritation or minor rash from electrode adhesive may occur in patients with sensitive skin, resolving spontaneously. There are no radiation risks, contrast agents, or pharmacological agents involved in the standard resting ECG.

Exercise ECG carries a small but real risk associated with physical exertion in patients with cardiac disease. Serious complications — ventricular fibrillation, sustained ventricular tachycardia, acute MI, or death — occur in approximately 1 in 10,000 exercise tests performed in appropriate facilities with qualified personnel and emergency resuscitation equipment. Contraindications to exercise ECG include recent MI within 48–72 hours, unstable angina, uncontrolled arrhythmia, decompensated heart failure, severe symptomatic aortic stenosis, and systolic blood pressure above 200 mmHg at rest. False positive ECG results — ST changes suggesting ischaemia in the absence of true coronary disease — occur in 5–10% of exercise tests, particularly in women, and require further investigation (stress echocardiography or cardiac MRI) to clarify.

No specific recovery is required after a standard resting ECG — patients can immediately resume normal activities. Results are typically available within minutes and are reviewed by the attending clinician or cardiologist. In emergency settings, the ECG is interpreted immediately and treatment initiated without delay. In elective outpatient settings, results are reviewed at the follow-up appointment or communicated to the patient's physician.

Serial ECGs — recording multiple ECGs over time — are standard practice in monitoring evolving myocardial infarction (documenting the progression of ST changes and Q wave formation), assessing response to antiarrhythmic therapy (QT interval monitoring with QT-prolonging drugs), evaluating pacemaker function at follow-up visits, and monitoring conduction intervals with medications that affect conduction (digoxin, amiodarone). Patients on medications that prolong the QT interval (including many antipsychotics, antidepressants, antimalarials, and antibiotics) require baseline and periodic ECG monitoring, as QTc prolongation above 500 ms indicates high risk of potentially fatal torsades de pointes arrhythmia.

The standard 12-lead ECG is one of the most cost-effective diagnostic tests in medicine. In the US, an outpatient ECG costs USD 100–300 before insurance, with insurance reducing patient out-of-pocket costs substantially. ECGs are covered by Medicare and most private insurance plans when clinically indicated. Exercise stress ECGs cost USD 500–1,500 in the US depending on whether physician supervision and interpretation are included. Holter monitoring costs USD 200–600 for 24-hour recording, with longer-duration patches (7–14 days) costing USD 400–1,000.

For patients accessing cardiac services abroad, the ECG is inexpensive in most countries. In India, a 12-lead ECG at a private cardiac clinic costs USD 5–15; exercise ECG (treadmill test) costs USD 30–80; and 24-hour Holter monitoring costs USD 30–60 — savings of 80–95% compared to US prices. Comprehensive cardiac evaluation packages in India, Thailand, and Turkey including ECG, echocardiogram, stress test, biochemical investigations, and specialist consultation are available for USD 200–500 versus USD 2,000–5,000 in the US or UK. Implantable loop recorder insertion for unexplained syncope costs approximately USD 800–2,000 in India versus USD 8,000–15,000 in the US.

Echocardiography (cardiac ultrasound) complements the ECG by providing structural and functional cardiac information (ejection fraction, wall motion, valve morphology and function, pericardial effusion) that the ECG cannot assess. Cardiac MRI offers the most detailed structural assessment and is the gold standard for myocardial viability, cardiomyopathy characterisation, and congenital heart disease. CT coronary angiography provides non-invasive anatomical assessment of coronary artery stenoses and is increasingly used as the first-line investigation for stable chest pain in intermediate-risk patients.

For arrhythmia investigation, electrophysiology studies (invasive intracardiac electrophysiology) are reserved for complex arrhythmias where non-invasive ECG monitoring has been inconclusive, or when catheter ablation is planned. Genetic testing is complementary to ECG in diagnosing inherited channelopathies such as Long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT), where the ECG findings guide but do not definitively diagnose the genetic condition. Wearable consumer ECG devices — smartwatches with single-lead ECG capability (Apple Watch, Samsung Galaxy Watch, Withings ScanWatch) — are increasingly used by patients for AF detection, though single-lead recordings are less diagnostic than standard 12-lead ECG and require clinical correlation.